150 related articles for article (PubMed ID: 31619988)
1. Si-Miao-Yong-An Decoction Protects Against Cardiac Hypertrophy and Dysfunction by Inhibiting Platelet Aggregation and Activation.
Su C; Wang Q; Zhang H; Jiao W; Luo H; Li L; Chen X; Liu B; Yu X; Li S; Wang W; Guo S
Front Pharmacol; 2019; 10():990. PubMed ID: 31619988
[No Abstract] [Full Text] [Related]
2. Si-Miao-Yong-An decoction attenuates cardiac fibrosis via suppressing TGF-β1 pathway and interfering with MMP-TIMPs expression.
Su C; Wang Q; Luo H; Jiao W; Tang J; Li L; Tian L; Chen X; Liu B; Yu X; Li S; Guo S; Wang W
Biomed Pharmacother; 2020 Jul; 127():110132. PubMed ID: 32403042
[TBL] [Abstract][Full Text] [Related]
3. Dissection of mechanisms of Chinese medicinal formula Si-Miao-Yong-an decoction protects against cardiac hypertrophy and fibrosis in isoprenaline-induced heart failure.
Zhao Y; Jiang Y; Chen Y; Zhang F; Zhang X; Zhu L; Yao X
J Ethnopharmacol; 2020 Feb; 248():112050. PubMed ID: 31265887
[TBL] [Abstract][Full Text] [Related]
4. Si-Miao-Yong-An decoction ameliorates cardiac function through restoring the equilibrium of SOD and NOX2 in heart failure mice.
Ren Y; Chen X; Li P; Zhang H; Su C; Zeng Z; Wu Y; Xie X; Wang Q; Han J; Guo S; Liu B; Wang W
Pharmacol Res; 2019 Aug; 146():104318. PubMed ID: 31228552
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the effective combinatorial components from Si-Miao-Yong-An decoction regarding the intervention on myocardial hypertrophy.
Chen XY; Chen XH; Li L; Su CP; Zhang YL; Jiang YY; Guo SZ; Liu B
J Ethnopharmacol; 2021 May; 271():113833. PubMed ID: 33465437
[TBL] [Abstract][Full Text] [Related]
6. Si-Miao-Yong-An Decoction Maintains the Cardiac Function and Protects Cardiomyocytes from Myocardial Ischemia and Reperfusion Injury.
Cui W; Xin S; Zhu L; Wang M; Hao Y; Zhao Y; Li Y; Hou Y
Evid Based Complement Alternat Med; 2021; 2021():8968464. PubMed ID: 34367308
[TBL] [Abstract][Full Text] [Related]
7. YQWY decoction reverses cardiac hypertrophy induced by TAC through inhibiting GATA4 phosphorylation and MAPKs.
Huang JJ; Xie Y; Li H; Zhang XX; Huang Q; Zhu Y; Gu P; Jiang WM
Chin J Nat Med; 2019 Oct; 17(10):746-755. PubMed ID: 31703755
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
9. Si-Miao-Yong-An Decoction attenuates isoprenaline-induced myocardial fibrosis in AMPK-driven Akt/mTOR and TGF-β/SMAD3 pathways.
Zhao Y; Sun D; Chen Y; Zhan K; Meng Q; Zhang X; Zhu L; Yao X
Biomed Pharmacother; 2020 Oct; 130():110522. PubMed ID: 32736236
[TBL] [Abstract][Full Text] [Related]
10. [The Observation of Liver and Kidney Injury and the Activation of Macrophages in the Overload Pressure Induced Cardiac Hypertrophy/Heart Failure Mouse Model].
Quan Y; Tian GE; Zhou JT; Wu WC; Liu XJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):331-336. PubMed ID: 32543138
[TBL] [Abstract][Full Text] [Related]
11. Main active components of Si-Miao-Yong-An decoction (SMYAD) attenuate autophagy and apoptosis via the PDE5A-AKT and TLR4-NOX4 pathways in isoproterenol (ISO)-induced heart failure models.
Liao M; Xie Q; Zhao Y; Yang C; Lin C; Wang G; Liu B; Zhu L
Pharmacol Res; 2022 Feb; 176():106077. PubMed ID: 35026404
[TBL] [Abstract][Full Text] [Related]
12. Si-Miao-Yong-An Decoction for Diabetic Retinopathy: A Combined Network Pharmacological and
Du A; Xie Y; Ouyang H; Lu B; Jia W; Xu H; Ji L
Front Pharmacol; 2021; 12():763163. PubMed ID: 34899317
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
[TBL] [Abstract][Full Text] [Related]
14. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
15. Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1β: In vivo and in vitro studies.
Zhai M; Liu Z; Zhang B; Jing L; Li B; Li K; Chen X; Zhang M; Yu B; Ren K; Yang Y; Yi W; Yang J; Liu J; Yi D; Liang H; Jin Z; Reiter RJ; Duan W; Yu S
J Pineal Res; 2017 Oct; 63(3):. PubMed ID: 28708271
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Effect and Mechanism of Si-Miao-Yong-An Decoction on Abdominal Aortic Aneurysm Based on Mice Experiment and Bioinformatics Analysis.
Xu Z; Zhang L; Huangfu N; Jiang F; Ji K; Wang S
Evid Based Complement Alternat Med; 2022; 2022():4766987. PubMed ID: 35685724
[TBL] [Abstract][Full Text] [Related]
17. AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice.
Zhang P; Hu X; Xu X; Fassett J; Zhu G; Viollet B; Xu W; Wiczer B; Bernlohr DA; Bache RJ; Chen Y
Hypertension; 2008 Nov; 52(5):918-24. PubMed ID: 18838626
[TBL] [Abstract][Full Text] [Related]
18. Promotion of classic neutral bile acids synthesis pathway is responsible for cholesterol-lowing effect of Si-miao-yong-an decoction: Application of LC-MS/MS method to determine 6 major bile acids in rat liver and plasma.
Liu Z; Zhang Y; Zhang R; Gu L; Chen X
J Pharm Biomed Anal; 2017 Feb; 135():167-175. PubMed ID: 28033554
[TBL] [Abstract][Full Text] [Related]
19. Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.
Franco V; Chen YF; Feng JA; Li P; Wang D; Hasan E; Oparil S; Perry GJ
Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):773-9. PubMed ID: 16922805
[TBL] [Abstract][Full Text] [Related]
20. Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a/β-catenin and Jak2/Stat3 pathways.
Zhang Y; Zhang L; Fan X; Yang W; Yu B; Kou J; Li F
Biomed Pharmacother; 2019 May; 113():108780. PubMed ID: 30889487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
